Cargando…
Synthesis and Structure–Activity Relationships of Novel Non-Steroidal CYP17A1 Inhibitors as Potential Prostate Cancer Agents
Twenty new compounds, targeting CYP17A1, were synthesized, based on our previous work on a benzimidazole scaffold, and their biological activity evaluated. Inhibition of CYP17A1 is an important modality in the treatment of prostate cancer, which remains the most abundant cancer type in men. The biol...
Autores principales: | Wróbel, Tomasz M., Rogova, Oksana, Sharma, Katyayani, Rojas Velazquez, Maria Natalia, Pandey, Amit V., Jørgensen, Flemming Steen, Arendrup, Frederic S., Andersen, Kasper L., Björkling, Fredrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961587/ https://www.ncbi.nlm.nih.gov/pubmed/35204665 http://dx.doi.org/10.3390/biom12020165 |
Ejemplares similares
-
Non-steroidal
CYP17A1 Inhibitors: Discovery and Assessment
por: Wróbel, Tomasz M., et al.
Publicado: (2023) -
Discovery of Novel Non-Steroidal Cytochrome P450 17A1 Inhibitors as Potential Prostate Cancer Agents
por: Wróbel, Tomasz M., et al.
Publicado: (2020) -
Exploring the Potential of Sulfur Moieties in Compounds Inhibiting Steroidogenesis
por: Wróbel, Tomasz M., et al.
Publicado: (2023) -
Promising Tools in Prostate Cancer Research: Selective Non-Steroidal Cytochrome P450 17A1 Inhibitors
por: Bonomo, Silvia, et al.
Publicado: (2016) -
No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer.
por: Dunning, A. M., et al.
Publicado: (1998)